| Virologic response following combined ledipasvir and sofosbuvir administration in patients with HCV genotype 1 and HIV co-infection A Osinusi, K Townsend, A Kohli, A Nelson, C Seamon, EG Meissner, ... Jama 313 (12), 1232-1239, 2015 | 260 | 2015 |
| Virological response after 6 week triple-drug regimens for hepatitis C: a proof-of-concept phase 2A cohort study A Kohli, A Osinusi, Z Sims, A Nelson, EG Meissner, LL Barrett, D Bon, ... The Lancet 385 (9973), 1107-1113, 2015 | 181 | 2015 |
| Effect of sofosbuvir and ribavirin treatment on peripheral and hepatic lipid metabolism in chronic hepatitis C virus, genotype 1–infected patients EG Meissner, YJ Lee, A Osinusi, Z Sims, J Qin, D Sturdevant, ... Hepatology 61 (3), 790-801, 2015 | 166 | 2015 |
| Re-treatment of chronic hepatitis C virus genotype 1 infection after relapse: an open-label pilot study A Osinusi, A Kohli, MM Marti, A Nelson, X Zhang, EG Meissner, R Silk, ... Annals of internal medicine 161 (9), 634-638, 2014 | 100 | 2014 |
| High adherence to all-oral directly acting antiviral HCV therapy among an inner-city patient population in a phase 2a study T Petersen, K Townsend, LA Gordon, S Sidharthan, R Silk, A Nelson, ... Hepatology international 10, 310-319, 2016 | 74 | 2016 |
| High Efficacy of Sofosbuvir/Ledipasvir for the Treatment of HCV Genotype 1 in Patients Coinfected With HIV on or off Antiretroviral therapy: Results from The NIAID ERADICATE … KS Townsend, A Osinusi, AK Nelson, A Kohli, C Gross, MA Polis, ... Hepatology 60, 240A-241A, 2014 | 45 | 2014 |
| Interferon-free treatment of hepatitis C virus in HIV/hepatitis C virus-coinfected subjects results in increased serum low-density lipoprotein concentration K Townsend, EG Meissner, S Sidharthan, M Sampson, AT Remaley, ... AIDS research and human retroviruses 32 (5), 456-462, 2016 | 44 | 2016 |
| O14 Use of sofosbuvir/ledipasvir fixed dose combination for treatment of HCV genotype-1 in patients coinfected with HIV A Osinusi, K Townsend, A Nelson, A Kohli, C Gross, MA Polis, PS Pang, ... Journal of Hepatology 1 (60), S7, 2014 | 31 | 2014 |
| Association of expanded Medicaid coverage with hospital length of stay after injury JL Holzmacher, K Townsend, C Seavey, S Gannon, M Schroeder, ... JAMA surgery 152 (10), 960-966, 2017 | 25 | 2017 |
| Effect of HIV co-infection on adherence to a 12-week regimen of hepatitis C virus therapy with ledipasvir and sofosbuvir K Townsend, T Petersen, LA Gordon, A Kohli, A Nelson, C Seamon, ... Aids 30 (2), 261-266, 2016 | 25 | 2016 |
| Favorable adverse event profile of sofosbuvir/ribavirin compared to boceprevir/interferon/ribavirin for treatment of hepatitis C S Narayanan, K Townsend, T Macharia, A Majid, A Nelson, RR Redfield, ... Hepatology international 8, 560-566, 2014 | 15 | 2014 |
| O11 Retreatment of relapsers to sofosbuvir/ribavirin with sofosbuvir/ledipasvir: complete and rapid virologic suppression by week 4 A Osinusi, M Marti, K Townsend, A Nelson, A Kohli, R Silk, P Pang, ... Journal of Hepatology 1 (60), S5-S6, 2014 | 14 | 2014 |
| Interleukin-23 Promotes Interferon-α Responsiveness in Hepatitis C Virus/HIV-Coinfected Patients M Odigie, A Osinusi, L Barrett, K Townsend, H Wang, AF Suffredini, ... AIDS research and human retroviruses 30 (8), 775-782, 2014 | 11 | 2014 |
| The diagnostic accuracy of procalcitonin for urinary tract infection in hospitalized older adults: a prospective study JJ Choi, MW McCarthy, KK Meltzer, A Cornelius-Schecter, A Jabri, ... Journal of general internal medicine, 1-7, 2022 | 10 | 2022 |
| Pill burden & treatment length reduce adherence to IFN-free hepatitis C therapy in an urban cohort TGL Petersen, K Townsend, M Calderon 21st Conference on Retroviruses and Opportunistic Infections, 3-6, 2014 | 8 | 2014 |
| The Desperate Hours: One Hospital's Fight to Save a City on the Pandemic's Front Lines M Brenner Flatiron Books, 2022 | 5 | 2022 |
| Directly acting triple drug anti-HCV therapy induces sustained virologic response with a six week regimen: a proof of concept phase 2a cohort study A Kohli, A Osinusi, Z Sims, A Nelson, EG Meissner, LL Barrett, D Bon, ... Lancet 385 (9973), 1107, 2015 | 4 | 2015 |
| Development of a practice-based community outreach intervention to prevent inequities in COVID-19 vaccinations CJ Gonzalez, K Meltzer, A Jabri, JJ Zhu, JD Lau, F Pelzman, J Tung American Journal of Medical Quality 37 (4), 348-355, 2022 | 3 | 2022 |
| I’m Treating Too Many Young People for the Coronavirus KK Meltzer Atlantic, 2020 | 3 | 2020 |
| Drug-Drug Interactions in Patients Co-infected With HCV and HIV—Reply A Osinusi, K Townsend, S Kottilil Jama 314 (2), 186-187, 2015 | 3 | 2015 |
